XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (9,590) $ (1,267)
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Depreciation and amortization 38 47
Equity-based compensation 1,893 192
Amortization of right-of-use assets 77  
Amortization of debt issuance costs   31
Amortization of debt discount   352
Change in the fair value of the derivative liability   (2,209)
Change in the fair value of the Simple Agreements for Future Equity   1,044
Gain on debt extinguishment   (443)
Changes in operating assets and liabilities:    
Grant receivables (1,496) (1,700)
Prepaid expenses and other assets (957) (270)
Other receivables 467 289
Accounts payable (864) 420
Accrued expenses (84) 1,320
Deferred grant income, current and other liabilities 2,222 512
Operating lease liabilities (51)  
Net cash used in operating activities (8,345) (1,682)
Cash flows from investing activities:    
Payments for property and equipment (138)  
Net cash used in investing activities (138)  
Cash flows from financing activities:    
Proceeds from the exercise of common stock options 325 14
Payments on loan payable (790)  
Proceeds from issuance of Simple Agreements for Future Equity   8,942
Proceeds from exercise of stock warrants   34
Deferred offering costs   (1,189)
Net cash (used in) provided by financing activities (465) 7,801
Effect of exchange rate changes on cash and cash equivalents (2) (8)
Net (decrease) increase in cash and cash equivalents (8,950) 6,111
Cash and cash equivalents    
Cash and cash equivalents-beginning of period 54,721 5,189
Cash and cash equivalents-end of period $ 45,771 11,300
Supplemental disclosures of non-cash financing activities:    
Issuance of Series B-1 convertible preferred stock upon conversion of debt   29,391
Deferred offering costs included in accounts payable   $ 1,252